Related Experiment Video
Updated: Jul 20, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments.
1Division of Research, VA Hospital, La Jolla, California, USA. jbookstein@popmail.ucsd.edu
Journal of Vascular and Interventional Radiology : JVIR
|December 1, 2000
Summary
Optimizing plasminogen-enriched pulse-spray thrombolysis significantly improved clot lysis in rabbits. This enhanced method achieved 89% lysis in one hour, outperforming tissue plasminogen activator alone.
Area of Science:
- Biomedical Engineering
- Thrombosis Research
- Pharmacology
Background:
- Thrombolysis aims to dissolve blood clots, improving outcomes in conditions like deep vein thrombosis.
- Tissue plasminogen activator (tPA) is a key thrombolytic agent, but its efficacy can be enhanced.
- Pulsed-spray delivery and plasminogen enrichment are strategies to improve thrombolysis.
Purpose of the Study:
- To refine pulsed plasminogen-enriched thrombolysis methods.
- To compare the efficacy of optimized plasminogen-enriched thrombolysis with tissue plasminogen activator (tPA) alone.
Main Methods:
- Experimental thrombolysis was induced in rabbits with inferior vena cava thrombosis.
- Parameters of pulsed plasminogen-enriched thrombolysis were systematically varied, including tPA pulse frequency, plasminogen amount, tPA concentration, and delivery method (pulsed vs. infused).
- Residual thrombus weight after one hour was measured to assess lysis efficacy.
Main Results:
- Optimized methods, using 3 mg tPA and approximately 0.9 mg plasminogen enrichment, showed efficacy directly related to pulse frequency (every 30 seconds optimal).
- Maximum efficacy was achieved with plasminogen enrichment up to approximately 1.8 mg per 1.24 g of clot.
- Optimized plasminogen-enriched thrombolysis achieved 89% clot lysis in one hour, significantly higher than the 74% lysis reported for optimized tPA alone.
Conclusions:
- Optimized in vivo plasminogen enrichment significantly accelerates thrombolysis of experimental clots.
- This approach offers a superior alternative to using optimized tissue plasminogen activator alone for clot dissolution.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...